Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients
Clinical trial NCT03333109 · COMPLETED
Trial details
- NCT number
- NCT03333109
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2020-01-13
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.